{
    "name": "Melatonin",
    "genericName": "Circadin (prolonged-release)",
    "tags": [
        "sleep aid",
        "insomnia",
        "circadian rhythm",
        "jet lag"
    ],
    "dosing": {
        "adult_acute": "0.5-10 mg at bedtime",
        "adult_maintenance": "1-5 mg/day",
        "notes": "Take 30-60 minutes before bedtime. Prolonged-release formulation (Circadin) approved for insomnia in patients ≥55. Lower doses (0.5-1 mg) may be as effective as higher doses for sleep. Used for jet lag, shift work disorder, and DSPD.",
        "canadian_clinical": {
            "starting_dose": "0.5-1 mg, 30-60 min before bedtime",
            "titration_schedule": "Can increase to 3-5 mg if 1 mg ineffective. Evidence limited for doses >10 mg.",
            "inpatient_strategy": "3-5 mg nocte for sleep regulation. Safer than benzodiazepines in elderly patients.",
            "outpatient_strategy": "Start 1-3 mg nocte. Good safety profile for chronic use. Useful in DSPD — take 2-3 h before desired sleep time.",
            "max_dose_evidence": "5 mg (approved); up to 10 mg used off-label",
            "max_dose_practice": "10 mg/day (off-label); most benefit seen at 1-5 mg."
        }
    },
    "cautions": {
        "renal": "Use with caution; limited data.",
        "hepatic": "Avoid in moderate-severe hepatic impairment.",
        "pregnancy": "Insufficient safety data — avoid."
    },
    "warnings": [
        "Morning drowsiness / next-day sedation at higher doses",
        "Headache, dizziness",
        "Interaction with warfarin (may enhance anticoagulant effect)",
        "Interaction with fluvoxamine (markedly increases melatonin levels)",
        "Not regulated as a drug in Canada (sold as natural health product) — variable quality",
        "Limited evidence for long-term efficacy"
    ],
    "citations": [
        "CANMAT Insomnia Recommendations 2021",
        "EMA Circadin Product Monograph",
        "Cochrane Review: Melatonin for Sleep Disorders 2022"
    ]
}
